中国先天性鼻泪管阻塞诊疗专家共识(2021年)  

Chinese expert consensus on diagnosis and treatment of congenital nasolacrimal duct obstruction(2021)

作　　者：中华医学会眼科学分会眼整形眼眶病学组 范先群[2] Oculoplastic and Orbital Disease Group of Chinese Ophthalmological Society of Chinese Medical Association;Fan Xianqun(不详;Department of Ophthalmology,Shanghai Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine,Shanghai 200011,China)

机构地区：[1]不详 [2]上海交通大学医学院附属第九人民医院眼科,200011

出　　处：《中华眼科杂志》2021年第11期814-818,共5页Chinese Journal of Ophthalmology

摘　　要：先天性鼻泪管阻塞是小儿眼科常见疾病, 发病率较高, 主要临床表现为患儿出生后不久出现持续性溢泪, 可伴有溢脓。治疗方法包括保守治疗和手术治疗, 目前临床存在治疗方法选择不当等问题, 如手术指征把握不准、手术操作不规范等。鉴于此, 中华医学会眼科学分会眼整形眼眶病学组经过充分讨论, 针对先天性鼻泪管阻塞的诊疗达成共识性意见, 以期规范我国相关临床工作, 提高临床诊疗水平。Congenital nasolacrimal duct obstruction is a common ophthalmic disease in children with a high incidence.The main clinical manifestation is persistent epiphora soon after birth,sometimes accompanied by an abscess.At present,the treatment methods used include conservative treatment and surgical treatment,but there exist some problems,such as improper surgical indications and non-standard surgical operation.In view of this,the Oculoplastic and Orbital Disease Group of Chinese Ophthalmological Society of Chinese Medical Association has reached a consensus after full discussion,in order to standardize the clinical diagnosis and treatment of congenital nasolacrimal duct obstruction in China.

关 键 词：泪器阻塞 综合疗法 诊疗准则(主题) 多数赞同 

分 类 号：R779.7[医药卫生—眼科]